Work

SGX70393 inhibits the T315I mutant of Bcr-Abl kinase and pre-empts drug resistance when combined with nilotinib or dasatinib

Year: 2007

Type: conference-abstract

Source: Molecular Cancer Therapeutics

Authors: Thomas O’Hare, Christopher A. Eide, Jeffrey W. Tyner, Amie S. Corbin, Matthew J. Wong, Sean G. Buchanan, Kevin R. Holme, Katayoun A. Jessen, Crystal M. Tang, H.J. Lewis, Richard Romero, S.K. Burley, Michael W. Deininger

Institution: Oregon Health & Science University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2264143935

Cites:

Cited by:

Related to: 20